Drug results: 1
| phenylbutanoic acid | Approved in combination with taurursodiol, as relyvrio, for the treatment of amyotrophic lateral sclerosis (ALS) in adults.The mechanism by which relyvrio exerts its therapeutic effects in patients with ALS is unknown. |
|








Citing DrugCentral © 2025.
License